We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAR icon
1326
Avis
CAR
$5.02B
– –
-56,737
Closed -$2M
CASY icon
1327
Casey's General Stores
CASY
$30.9B
– –
-6,539
Closed -$1.02M
CCI icon
1328
Crown Castle
CCI
$32.2B
– –
-42,138
Closed -$5.49M
CDNA icon
1329
CareDx
CDNA
$2.42B
– –
-48,237
Closed -$1.74M
CDXS icon
1330
Codexis
CDXS
$158M
– –
-68,116
Closed -$1.25M
CENTA icon
1331
Central Garden & Pet Co Class A
CENTA
$2.44B
– –
-46,179
Closed -$911K
CL icon
1332
Colgate-Palmolive
CL
$74.4B
– –
-90,860
Closed -$6.51M
CLB icon
1333
Core Laboratories
CLB
$521M
– –
-133,005
Closed -$6.95M
CMA
1334
DELISTED
Comerica
CMA
– –
-67,042
Closed -$4.87M
CMBM
1335
DELISTED
Cambium Networks
CMBM
– –
-200,000
Closed -$1.92M
CMG icon
1336
Chipotle Mexican Grill
CMG
$41.5B
– –
-674,950
Closed -$9.89M
CMP icon
1337
Compass Minerals
CMP
$1.15B
– –
-11,563
Closed -$635K
CNK icon
1338
Cinemark Holdings
CNK
$4.32B
– –
-68,849
Closed -$2.49M
CNP icon
1339
CenterPoint Energy
CNP
$26.8B
– –
-82,561
Closed -$2.36M
VISN
1340
Vistance Networks Inc
VISN
$2.52B
– –
-205,339
Closed -$3.23M
CORT icon
1341
Corcept Therapeutics
CORT
$12B
– –
-81,348
Closed -$907K
CRSP icon
1342
CRISPR Therapeutics
CRSP
$5.17B
– –
-4,945
Closed -$233K
CTVA icon
1343
Corteva
CTVA
$51.3B
– –
-121,227
Closed -$3.58M
CW icon
1344
Curtiss-Wright
CW
$25.5B
– –
-19,133
Closed -$2.43M
CYRX icon
1345
CryoPort
CYRX
$762M
– –
-51,342
Closed -$941K
DAR icon
1346
Darling Ingredients
DAR
$9.44B
– –
-13,397
Closed -$266K
DCI icon
1347
Donaldson
DCI
$11.4B
– –
-13,541
Closed -$690K
DDS icon
1348
Dillards
DDS
$9.56B
– –
-14,882
Closed -$926K
DEO icon
1349
Diageo
DEO
$53.6B
– –
-15,891
Closed -$2.74M
DHC
1350
Diversified Healthcare Trust
DHC
$2.14B
– –
-123,778
Closed -$1.02M
52 53
54
55 56

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.